Eledon Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
ELDN
CUSIP
28617K101
Type
Equity
Class
COM
Num filings
90
Total reported value, excl. options
$111 M
Manager Report Date Value ($000) Shares Option Type